Yu AM[au] - Search Results

Year	Number of Results
1985	1
1989	1
1992	1
1993	2
1997	2
2000	2
2001	4
2002	1
2003	6
2004	5
2005	4
2006	7
2007	4
2008	12
2009	13
2010	10
2011	12
2012	10
2013	9
2014	7
2015	8
2016	17
2017	15
2018	20
2019	17
2020	10
2021	11
2022	19
2023	10

1

RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies.

Traber GM, Yu AM. Traber GM, et al. Among authors: yu am. J Pharmacol Exp Ther. 2023 Jan;384(1):133-154. doi: 10.1124/jpet.122.001234. Epub 2022 Jun 9. J Pharmacol Exp Ther. 2023. PMID: 35680378 Free PMC article. Review.

2

RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.

Yu AM, Choi YH, Tu MJ. Yu AM, et al. Pharmacol Rev. 2020 Oct;72(4):862-898. doi: 10.1124/pr.120.019554. Pharmacol Rev. 2020. PMID: 32929000 Free PMC article.

3

ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.

Choi YH, Yu AM. Choi YH, et al. Among authors: yu am. Curr Pharm Des. 2014;20(5):793-807. doi: 10.2174/138161282005140214165212. Curr Pharm Des. 2014. PMID: 23688078 Free PMC article. Review.

4

RNA therapeutics: From biochemical pharmacology to technology development and clinical applications.

Ning B, Yu AM. Ning B, et al. Among authors: yu am. Biochem Pharmacol. 2021 Jul;189:114567. doi: 10.1016/j.bcp.2021.114567. Epub 2021 Apr 16. Biochem Pharmacol. 2021. PMID: 33865832 Free PMC article. No abstract available.

5

Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination.

Yu AM, Tu MJ. Yu AM, et al. Pharmacol Ther. 2022 Feb;230:107967. doi: 10.1016/j.pharmthera.2021.107967. Epub 2021 Aug 14. Pharmacol Ther. 2022. PMID: 34403681 Free PMC article. Review.

6

A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis.

Chen Y, Zhou Y, Han F, Zhao Y, Tu M, Wang Y, Huang C, Fan S, Chen P, Yao X, Guan L, Yu AM, Gonzalez FJ, Huang M, Bi H. Chen Y, et al. Among authors: yu am. Theranostics. 2020 Jun 1;10(16):7193-7210. doi: 10.7150/thno.44877. eCollection 2020. Theranostics. 2020. PMID: 32641987 Free PMC article.

7

ATR Inhibition in Advanced Urothelial Carcinoma.

Leibrandt RC, Tu MJ, Yu AM, Lara PN, Parikh M. Leibrandt RC, et al. Among authors: yu am. Clin Genitourin Cancer. 2023 Apr;21(2):203-207. doi: 10.1016/j.clgc.2022.10.016. Epub 2022 Nov 4. Clin Genitourin Cancer. 2023. PMID: 36604210 Free article. Review.

8

Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functions.

Yi WR, Tu MJ, Yu AX, Lin J, Yu AM. Yi WR, et al. Among authors: yu am. Bioengineered. 2022 May;13(5):12489-12503. doi: 10.1080/21655979.2022.2076399. Bioengineered. 2022. PMID: 35579419 Free PMC article.

9

High-throughput determination of RNA structures.

Strobel EJ, Yu AM, Lucks JB. Strobel EJ, et al. Among authors: yu am. Nat Rev Genet. 2018 Oct;19(10):615-634. doi: 10.1038/s41576-018-0034-x. Nat Rev Genet. 2018. PMID: 30054568 Free PMC article. Review.

10

RNA therapy: Are we using the right molecules?

Yu AM, Jian C, Yu AH, Tu MJ. Yu AM, et al. Pharmacol Ther. 2019 Apr;196:91-104. doi: 10.1016/j.pharmthera.2018.11.011. Epub 2018 Dec 4. Pharmacol Ther. 2019. PMID: 30521885 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

208 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Results by year